Active metabolic lithiasis: A condition that requires proper evaluation and monitoring

Pricop,Cătălin; Ivănuță,Marius; Puia,Dragoş

doi:10.3892/etm.2022.11651

Active metabolic lithiasis: A condition that requires proper evaluation and monitoring

Authors:
- Cătălin Pricop
- Marius Ivănuță
- Dragoş Puia
View Affiliations

Affiliations: Department of Urology, ‘Grigore T. Popa’ University of Medicine and Pharmacy, 700115 Iași, Romania, Department of Urology, ‘Dr C. I. Parhon’ Hospital, 700503 Iași, Romania
Published online on: October 10, 2022 https://doi.org/10.3892/etm.2022.11651
Article Number: 715
Copyright: © Pricop et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Kidney stone evolution is different among patients, with some exhibiting kidney stones once in a lifetime and others experiencing multiple recurrences, with some even presenting with them at short intervals of time. The present study analyzed the risk of recurrence in order to organize a personalized prophylaxis and follow‑up for the patients at risk. Prior to the analysis, the patients completed the liquids, antecedents, medication, associated pathologies and aliments questionnaire. A total of 350 patients with kidney stones were consecutively enrolled between April 2019 and April 2022. The spectroscopic analysis of stone samples was performed with the Bruker Alpha II spectrometer, while the stone morphology was assessed using the Olympus SZ61TR stereomicroscope. Intact stones were sectioned and their cores were analyzed separately. Patients with metabolically active lithiasis had stones made of cystine (CYS), uric acid (UA), brushite or calcium oxalate dihydrate. Among patients aged 18‑30 years, two morphological factors defining the metabolically active lithiasis were identified: Randall's plaques [odds ratio (OR), 8.8] and poor stone organization (OR, 12.0). In patients aged 31‑40 years, one criterion for the diagnosis of metabolically active lithiasis was the identification of pale stone color (OR, 12.0). Among the 149 patients aged >50 years, 24.8% (n=37) had UA lithiasis. Furthermore, the association of the defining elements of the metabolic syndrome significantly increased the likelihood of the lithiasis recurrence (P=0.03; OR, 4.3). The presence of kidney stones in the family history was significantly associated with the type of stone (P=0.004). Among the 7 patients with CYS stones, 71.4% of them had family history of lithiasis. The study findings suggest that the identification of Randall plaques, a light stone color or a low degree of stone organization is associated with increased odds of lithiasis recurrence.

View Figures

View References

1	Rule AD, Lieske JC and Pais VM Jr: Management of kidney stones in 2020. JAMA. 323:1961–1962. 2020.PubMed/NCBI View Article : Google Scholar
2	Edvardsson VO, Indridason OS, Haraldsson G, Kjartansson O and Palsson R: Temporal trends in the incidence of kidney stone disease. Kidney Int. 83:146–152. 2013.PubMed/NCBI View Article : Google Scholar
3	Tasian GE, Kabarriti AE, Kalmus A and Furth SL: Kidney stone recurrence among children and adolescents. J Urol. 197:246–252. 2017.PubMed/NCBI View Article : Google Scholar
4	Wollin DA, Kaplan AG, Preminger GM, Ferraro PM, Nouvenne A, Tasca A, Croppi E, Gambaro G and Heilberg IP: Defining metabolic activity of nephrolithiasis-appropriate evaluation and follow-up of stone formers. Asian J Urol. 5:235–242. 2018.PubMed/NCBI View Article : Google Scholar
5	Daudon M, Jungers P and Bazin D: Stone morphology: Implication for pathogenesis. AIP Conference Proceedings. 104:199–215. 2008.
6	Pricop C, Ivănuţă M, Stan A, Anton-Păduraru DT, Radavoi GD, Jinga V, Proca TM and Puia D: Correlations between stones composition, dietary and comorbidities context of the lithiasic patient. Rom J Morphol Embryol. 61:1227–1233. 2020.PubMed/NCBI View Article : Google Scholar
7	Daudon M. Recueil des spectres infra-rouges des calculs de l'arbre urinaire et des voies biliaires et des cristalluries. Laboratoire Cristal, 2015.
8	Romero V, Akpinar H and Assimos DG: Kidney stones: A global picture of prevalence, incidence, and associated risk factors. Rev Urol. 12:e86–e96. 2010.PubMed/NCBI
9	Kirkali Z, Rasooly R, Star RA and Rodgers GP: Urinary stone disease: Progress, status, and needs. Urology. 86:651–653. 2015.PubMed/NCBI View Article : Google Scholar
10	Kachroo N, Lange D, Penniston KL, Stern J, Tasian G, Bajic P, Wolfe AJ, Suryavanshi M, Ticinesi A, Meschi T, et al: Meta-analysis of clinical microbiome studies in urolithiasis reveal age, stone composition, and study location as the predominant factors in urolithiasis-associated microbiome composition. MBio. 12(e0200721)2021.PubMed/NCBI View Article : Google Scholar
11	Pricop C and Puia D: Urolithiasis in young patients: The cost increasing! Romanian are J Urol. 16(150)2017.
12	Tzortzis V, Mamoulakis C, Rioja J, Gravas S, Michel MC and de la Rosette JJ: Medical expulsive therapy for distal ureteral stones. Drugs. 69:677–692. 2009.PubMed/NCBI View Article : Google Scholar
13	Varkarakis J, Protogerou V, Albanis S, Sofras F and Deliveliotis C: Comparison of success rates and financial cost of extracorporeal shock-wave lithotripsy in situ and after manipulation for proximal ureteral stones. Urol Res. 31:286–290. 2003.PubMed/NCBI View Article : Google Scholar
14	Ljunghall S and Hedstrand H: Epidemiology of renal stones in a middle-aged male population. Acta Med Scand. 97:439–445. 1975.PubMed/NCBI View Article : Google Scholar
15	Galan P and Hercberg S: SU.VI.MAX et NutriNet-Santé: Les enseignements des grandes cohortes. Rev Prat. 68:37–40. 2018.PubMed/NCBI(In French).
16	Skolarikos A, Straub M, Knoll T, Sarica K, Seitz C, Petřík A and Türk C: Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 67:750–763. 2015.PubMed/NCBI View Article : Google Scholar
17	Daudon M, Jungers P, Bazin D and Williams JC Jr: Recurrence rates of urinary calculi according to stone composition and morphology. Urolithiasis. 46:459–470. 2018.PubMed/NCBI View Article : Google Scholar
18	An hypothesis for the origin of renal calculus. N Engl J Med. 214:234–237. 1936.
19	Low RK, Stoller ML and Schreiber CK: Metabolic and urinary risk factors associated with Randall's papillary plaques. J Endourol. 14:507–510. 2000.PubMed/NCBI View Article : Google Scholar
20	Daudon M, Bazin D and Letavernier E: Randall's plaque as the origin of calcium oxalate kidneys tones. Urolithiasis. 43 (Suppl 1):S5–S11. 2015.PubMed/NCBI View Article : Google Scholar
21	Matlaga BR, Lingeman JC Jr, Kim SC, Kuo RL, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC and Lingeman JE: Endoscopic evidence of calculus attachment to Randall's plaque. J Urol. 175:1720–1724. 2006.PubMed/NCBI View Article : Google Scholar
22	Bouslama S, Boutefnouchet A, Hannache B, Djemil T, Kadi A, Dahdouh A, Saka S and Daudon M: Composition of 359 kidney stones from the East region of Algeria. Prog Urol. 26:41–49. 2016.PubMed/NCBI View Article : Google Scholar : (In French).
23	Ruggera L, Chiodini S and Gambaro G: Does Randall's plaque represent a necessary condition in the pathogenesis of the idiopathic calcium oxalate stones? In: Abstracts of the 11th international symposium on urolithiasis, Nice, 2-5 September 2008. UrolRes. Vol 36. pp162-163, 2008.
24	Letavernier E, Vandermeersch S, Traxer O, Tligui M, Baud L, Ronco P, Haymann JP and Daudon M: Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic? Medicine. 94(e566)2015.PubMed/NCBI View Article : Google Scholar
25	Curhan GC, Willett WC, Rimm EB and Stampfer MJ: Family history and risk of kidneystones. J Am Soc Nephrol. 8:1568–1573. 1997.PubMed/NCBI View Article : Google Scholar
26	Ahmadi Asr Badr Y, Hazhir S and Hasanzadeh K: Family history and age at the onset of upper urinary tract calculi. Urol J. 4:142–146. 2007.PubMed/NCBI
27	Semins MJ, Shore AD, Makary MA, Magnuson T, Johns R and Matlaga BR: The association of increasing body mass index and kidney stone disease. J Urol. 183:571–575. 2010.PubMed/NCBI View Article : Google Scholar
28	Daudon M, Lacour B and Jungers P: Influence of body size on urinary stone composition in men and women. Urol Res. 34:193–199. 2006.PubMed/NCBI View Article : Google Scholar
29	Taylor EN, Stampfer MJ and Curhan GC: Obesity, weight gain, and the risk of kidneystones. JAMA. 293:455–462. 2005.PubMed/NCBI View Article : Google Scholar
30	Daudon M, Lacour B and Jungers P: High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant. 20:468–469. 2005.PubMed/NCBI View Article : Google Scholar
31	World Health Organisation (WHO): Obesity and Overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight, 2021. Accessed June 23, 2022.
32	Cirillo M and Laurenzi M: Elevated blood pressure and positive history of kidney stones: Results from a population-based study. J Hypertens. 6:S485–S486. 1988.PubMed/NCBI View Article : Google Scholar
33	Lee TT, Elkoushy MA and Andonian S: Are stone analysis results different with repeated sampling? Can Urol Assoc J. 8:E317–E322. 2014.PubMed/NCBI View Article : Google Scholar
34	Halbritter J, Baum M, Hynes AM, Rice SJ, Thwaites DT, Gucev ZS, Fisher B, Spaneas L, Porath JD, Braun DA, et al: Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol. 26:543–551. 2015.PubMed/NCBI View Article : Google Scholar
35	Howles SA and Thakker RV: Genetics of kidney stone disease. Nat Rev Urol. 17:407–421. 2020.PubMed/NCBI View Article : Google Scholar